Items Tagged ‘heart disease’

October 29, 2020 · Leave a Comment

Long-term safety, benefits of stem therapy for heart failure

By Susan Buckles Susan Buckles (@susanbuckles)

The largest regenerative medicine clinical trial to date for heart failure finds stem cell therapy is safe over the long term and benefits patients with advanced left ventricular enlargement. This multinational research, co-led by Andre Terzic, M.D., Ph.D., director of Mayo Clinic’s Center for Regenerative Medicine, and published in ESC Heart Failure, offers guidance in […]

View full entry Comment on this

Tags: cardiac regeneration, cardiopoietic stem cells, CHART-1 Trial, Dr. Andre Terzic, heart disease, Mayo Clinic Center for Regeneration, stem cell therapy


February 14, 2020 · Leave a Comment

Evolution of cardiac regeneration

By Jennifer Schutz Jennifer Schutz (@jenniferschutz)

February is American Heart Month, a time to acknowledge advancements in a new generation of care. This year focus is placed on repairing damaged heart tissue and restoring heart function after a heart attack. The Mayo Clinic Center for Regenerative Medicine is leading research into cardiac regeneration. Accounting for nearly 20 million of all deaths, […]

View full entry Comment on this

Tags: #American Heart Month, #Dr. Michael Sabbah, cardiac regeneration, Dr. Atta Behfar, heart attack, heart disease, Mayo Clinic Center for Regenerative Medicine


December 19, 2019 · Leave a Comment

Off the Shelf Vessels: A Regenerative Approach for Coronary Artery Bypass

By Jennifer Schutz Jennifer Schutz (@jenniferschutz)

Growing blood vessels in a lab for human use may sound like a futuristic dream. However, Mayo Clinic researchers are seeking to do just that to advance a regenerative approach to coronary bypass graft surgery. Through a Regenerative Medicine Minnesota grant, a Mayo research team is developing tissue that could grow into a blood vessel […]

View full entry Comment on this

Tags: blood vessels, bypass, coronary artery disease, Dr. Leigh Griffiths, heart disease, vascular tissue engineering


July 26, 2019 · Leave a Comment

Research for Infants with HLHS Moves Forward

By Jennifer Schutz Jennifer Schutz (@jenniferschutz)

Hypoplastic left heart syndrome (HLHS) is a complex and rare heart defect present at birth in which the left side of a child’s heart is severely underdeveloped. At Mayo Clinic, physicians and researchers in the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome are looking for ways to delay or even prevent heart failure […]

View full entry Comment on this

Tags: clinical trial, Dr. Timothy Nelson, heart disease, HLHS, hypoplastic left heart syndrome, Medical Research, phase I trial, regenerative medicine, stem cells, Todd and Karen Wanek Family Program for HLHS


November 19, 2014 · Leave a Comment

Mayo Scientist Receives American Heart Association 2014 Basic Research Prize

By centerforregmedmc centerforregmedmc (@centerforregmedmc)

The American Heart Association (AHA) awarded the 2014 Basic Research Prize to Andre Terzic, M.D., Ph.D., of Mayo Clinic. The award, presented at the annual meeting of the American Heart Association in Chicago, recognizes outstanding contributions to the advancement of cardiovascular science. Dr. Terzic was commended for pioneering applications of emerging technologies to advance the diagnosis […]

View full entry Comment on this

Tags: American Heart Association, Andre Terzic, cardiology, heart disease, Mayo Clinic, Minnesota news release, regenerative medicine, stem cells


January 21, 2014 · Leave a Comment

Mayo Clinic Discovery Leads to FDA Approval for Stem Cell Trial for Heart Failure Patients

By centerforregmedmc centerforregmedmc (@centerforregmedmc)

Cardio3 BioSciences, an international Mayo Clinic collaborator, has received FDA approval for a phase III pivotal clinical trial of its stem cell therapy. The trial will test the Mayo Clinic discovery of cardiopoietic (cardiogenically-instructed) stem cells designed to improve heart health in people suffering from heart failure. The multisite U.S. trial, called CHART-2, will aim to recruit […]

View full entry Comment on this

Tags: Andre Terzic, Atta Behfar, cardiac regeneration, Cardio3 Biosciences, European stem cell trial, heart disease, Mayo Clinic, regenerative medicine, stem cells


Contact Us · Privacy Policy